122 related articles for article (PubMed ID: 38525814)
21. A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
De Blasio A; Di Fiore R; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Scerri C; Vento R; Tesoriere G
J Cell Physiol; 2020 Feb; 235(2):629-637. PubMed ID: 31313842
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
[TBL] [Abstract][Full Text] [Related]
23. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
[TBL] [Abstract][Full Text] [Related]
24. The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer.
Jin XX; Gao C; Wei WX; Jiao C; Li L; Ma BL; Dong C
Bioengineered; 2022 Apr; 13(4):9097-9105. PubMed ID: 35382692
[TBL] [Abstract][Full Text] [Related]
25. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown.
Kim SH; Hahm ER; Arlotti JA; Samanta SK; Moura MB; Thorne SH; Shuai Y; Anderson CJ; White AG; Lokshin A; Lee J; Singh SV
Breast Cancer Res Treat; 2016 May; 157(1):41-54. PubMed ID: 27097807
[TBL] [Abstract][Full Text] [Related]
26. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
[TBL] [Abstract][Full Text] [Related]
27. [JAG1 affects monocytes-macrophages to reshape the pre-metastatic niche of triple-negative breast cancer through LncRNA MALAT1 in exosomes].
Xu M; Shi Y; Liu J; Wu M; Zhang F; He Z; Tang M
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1525-1535. PubMed ID: 37814867
[TBL] [Abstract][Full Text] [Related]
28. p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target.
Deng S; Wang M; Wang C; Zeng Y; Qin X; Tan Y; Liang B; Cao Y
Mol Biol Rep; 2023 Jan; 50(1):577-587. PubMed ID: 36352176
[TBL] [Abstract][Full Text] [Related]
29. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
30. Association between extract of Euphorbia szovitsii and expression level of microRNAs in MDA-MB-231 cell line.
Asadi-Samani M; Mahmoudian-Sani MR
Mol Biol Rep; 2022 May; 49(5):3531-3537. PubMed ID: 35132492
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of MiR-146a-5p Upregulates lncRNA HOTAIR in Triple-Negative Breast Cancer Cells and Predicts Poor Prognosis.
Liang H; Huang W; Wang Y; Ding L; Zeng L
Technol Cancer Res Treat; 2019; 18():1533033819882949. PubMed ID: 31672084
[TBL] [Abstract][Full Text] [Related]
32. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
Liu G; Wang P; Zhang H
J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
[TBL] [Abstract][Full Text] [Related]
33. miR-744/eNOS/NO axis: A novel target to halt triple negative breast cancer progression.
El Kilany FH; Youness RA; Assal RA; Gad MZ
Breast Dis; 2021; 40(3):161-169. PubMed ID: 33749631
[TBL] [Abstract][Full Text] [Related]
34. Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets.
Kaya M; Abuaisha A; Suer I; Emiroglu S; Abanoz F; Palanduz S; Cefle K; Ozturk S
Eur J Breast Health; 2024 Apr; 20(2):102-109. PubMed ID: 38571691
[TBL] [Abstract][Full Text] [Related]
35. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-146a-5p Promotes Acute Pancreatitis through Activating the TLR9/NLRP3 Signaling Pathway by Targeting TRAF6 In Vitro Rat Model.
Deng D; Su Z; Wei B; Zhou J; Yang H; Liang Z
Comput Math Methods Med; 2022; 2022():1747470. PubMed ID: 36276993
[TBL] [Abstract][Full Text] [Related]
37. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
38. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
[No Abstract] [Full Text] [Related]
39. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
40. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
